logo

For the Inventor, By the Inventor

Odawara, Japan

Sachiko Miyamoto

This inventor holds 4 USPTO granted patents. Top assignees: Meiji Seika Kaisha, Ltd., Meji Seika Kaisha Ltd.. Active years: 2002-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sachiko Miyamoto. Retrieved from https://idiyas.com/inventor/sachiko-miyamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4

% Patents Active = 25.0

Average Co-Inventor Count = 9.3

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Kanagawa-Ken, JP (2006)
  • Odawara, JP (2002 - 2007)

Company Filing History:

goldMedal3 out of 382 
 
Meiji Seika Kaisha, Ltd.
 patents
silverMedal1 out of 5 
 
Meji Seika Kaisha Ltd.
 patents

Years Active: 2002-2007

Loading Chart...
4 patents (USPTO):Explore Patents
1. 7238812 - Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents (2007-07-03),
2. 7022860 - Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents (2006-04-04),
3. 7002009 - Crystalline tricyclic triazolobenzazepine derivative (2006-02-21),
4. 6372735 - Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic (2002-04-16),

Title: Sachiko Miyamoto: Innovator in Antiallergic Agents

Introduction

Sachiko Miyamoto is a notable inventor based in Odawara, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiallergic agents. With a total of 4 patents to her name, her work has had a considerable impact on medical science.

Latest Patents

Miyamoto's latest patents include innovative compounds known as tricyclic triazolobenzazepine derivatives. These compounds are designed to serve as antiallergic agents and exhibit excellent bioavailability. The patents detail a process for producing these compounds, which involves several chemical reactions to create pharmacologically acceptable salts and solvates. The compounds are represented by specific formulas, showcasing their potential in treating allergic conditions.

Career Highlights

Throughout her career, Sachiko Miyamoto has worked with prominent companies such as Meiji Seika Kaisha, Ltd. and Meiji Seika Kaisha Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Miyamoto has collaborated with several professionals in her field, including Yumiko Okada and Yasuo Ohtsuka. These collaborations have fostered a productive environment for innovation and development in her research endeavors.

Conclusion

Sachiko Miyamoto's contributions to the field of antiallergic agents highlight her role as a significant inventor in the pharmaceutical industry. Her innovative work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…